Cargando…
Acute cardiac failure and hepatic ischemia induced by disopyramide phosphate.
Two patients abruptly developed congestive heart failure and elevation in serum transaminase levels when given disopyramide phosphate; enzyme abnormalities and hemodynamic status corrected upon withdrawal of the drug. Both patients had underlying ischemic cardiomyopathy. Myocardial infarction, pulmo...
Autores principales: | Scheinman, S. J., Poll, D. S., Wolfson, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2595921/ https://www.ncbi.nlm.nih.gov/pubmed/7222741 |
Ejemplares similares
-
The Clinical Development of Disopyramide
por: Ankier, S. I.
Publicado: (1976) -
Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019) -
The Role of Disopyramide after Myocardial Infarction
por: Jones, M. B. S.
Publicado: (1976) -
Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients
por: Adler, Arnon, et al.
Publicado: (2017) -
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
por: Maurizi, Niccolò, et al.
Publicado: (2023)